Margit
Margit Bauer, Biberach DE
Patent application number | Description | Published |
---|---|---|
20080293680 | Substituted Ethane-1,2-Diamines for the Treatment of Alzheimer's Disease II - The invention relates to a compound of the formula (I), wherein R | 11-27-2008 |
Margit Bukohl, Marl DE
Patent application number | Description | Published |
---|---|---|
20110054080 | METHOD FOR PRODUCING COATED RUBBER PARTICLES AND COATED RUBBER PARTICLES - The method describes a novel production method for coated particles made of rubber granules, the coating, the particles thus coated, and the use of the coated particles. | 03-03-2011 |
20110305850 | METHOD FOR THE PRODUCTION OF COATED RUBBER PARTICLES, COATED RUBBER PARTICLES, AND SOLVENT-FREE COATING FORMULATION - The invention describes a novel production process for coated particles composed of granulated-rubber material, the coating, the particles coated therewith and the uses of the coated particles. The coating formulation is solvent-free. | 12-15-2011 |
Margit Doth, Leverkusen DE
Patent application number | Description | Published |
---|---|---|
20110207778 | Active compound combination comprising azadirachtin and a substituted enaminocarbonyl compound - Disclosed are novel active compound combinations comprising at least one substituted enaminocarbonyl compound and azadirachtin, which combinations are highly suitable for controlling animal pests such as insects and unwanted acarids. Methods of controlling insects and acarids are also disclosed. | 08-25-2011 |
20130287749 | FORMULATION FOR SNAIL BAITS COMPRISING ORGANOPHOSPHONIC ACIDS, METAL SALTS AND METHIOCARB - The present invention relates to novel phosphonic acid formulations and to their use as slug and snail baits, and to the corresponding slug and snail baits, to a process for their preparation and to their use for controlling slugs and snails. | 10-31-2013 |
Margit Gföhler, Wien AT
Patent application number | Description | Published |
---|---|---|
20160000983 | Ventricular assist device - The invention relates to a ventricular assist device for intraventricular placement inside a human heart including an anchor element configured to be mounted to the heart in the region of the apex; and a pump connected to the anchor element comprising a preferably tubular housing having an intraventricular inlet and an intraventricular outlet and further comprising a drive for driving a rotor arranged within the housing, thereby providing pulsatile flow acceleration in the left ventricle synchronized with the heart beat and according to volume requirements in the left ventricle. | 01-07-2016 |
Margit Haerting, Mowbray ZA
Patent application number | Description | Published |
---|---|---|
20150236140 | CURRENT SWITCHING TRANSISTOR - An electronic device and a method of fabricating an electronic device are disclosed. The device includes a body of semiconductor material, and a conductive material defining at least three conducting contacts to form respective terminals. The semiconductor material and the conducting contacts overlap at least partially to define the device, so that the electrical characteristics of the device between any pair of terminals correspond to those of a varistor. The body of semiconductor material may be a layer deposited by printing or coating. The varistor characteristics between each pair of terminals enable switching of an electrical current between one terminal and any two other terminals in such a manner that when there is a positive current into a first terminal, there is a negligible current through a second terminal at which a positive potential is applied and a positive current out of a third terminal which is held at a negative potential with respect to the second terminal. When there is a negative current outwards of the first terminal, there is a positive current into the second terminal and a negligible current through the third terminal. | 08-20-2015 |
Margit Hiesinger, Hilden DE
Patent application number | Description | Published |
---|---|---|
20130189726 | METHOD FOR PREPARING AND/OR PROCESSING A BIOLOGICAL SAMPLE USING A MALODOUR COUNTERACTANT - The present invention pertains to a biotechnological method for preparing and/or processing a biological sample, in particular for isolating at least one target biomolecule therefrom, which characterised in that at least one malodour counteractant is used for preventing, reducing, masking and/or suppressing malodour and/or malodour formation during the preparation and/or processing of said biological sample. | 07-25-2013 |
Margit Hiesinger, Wuppertal DE
Patent application number | Description | Published |
---|---|---|
20130105393 | NEW STORAGE, COLLECTION OR ISOLATION DEVICE | 05-02-2013 |
20130112622 | NEW LIQUID PROCESSING DEVICE - The present invention refers to a device, comprising a hollow body having at least one open end and at least one barrier inside of the hollow body, which is non-permeable for liquids and solids under ambience conditions, however, becomes liquid-permeable by applying an external force like pressure, drag force or driving power to said barrier, wherein said barrier is spaced from at least one open end of the hollow body, the use of such a device for processing of a liquid sample, a method for preparation of said device and a method for isolation or purification of any biomolecules using said device. | 05-09-2013 |
20140134718 | FILTER MODULE IN BIOMOLECULE ISOLATION - The present invention relates to a device for rapid isolation of target molecules from cell lysates and other liquid mixtures comprising particulate material, a method for isolating the target molecules, in particular nucleic acids, using said device and a kit for carrying out said method comprising said device. | 05-15-2014 |
Margit Hölzl, Vorchdorf AT
Patent application number | Description | Published |
---|---|---|
20100077918 | CYLINDER FOR HIGH-PRESSURE HYDRAULICS - A cylinder for high-pressure hydraulics is disclosed, with a cylinder sleeve extending between a cylinder base and a cylinder head composed of an inner tube and an outer sleeve made from fiber-reinforced plastic placed on the inner tube. According to the invention, a weight reduction without loss of rigidity may be achieved, whereby the inner tube of the cylinder sleeve screwed to the cylinder base and joined to the outer sleeve in a thrust-resistant or shear-resistant manner engages with the cylinder head in a tensile-resistant manner. | 04-01-2010 |
Margit Hornof, Vienna AT
Patent application number | Description | Published |
---|---|---|
20100028399 | Use of Polymers - The present invention relates to the use of a thiol-group-containing polymer for preparing an implant for tissue augmentation, wherein the basis polymer is a polysaccharide. | 02-04-2010 |
Margit Kakas, Karlstein DE
Patent application number | Description | Published |
---|---|---|
20100203173 | SILICA DISPERSION - Dispersion containing, in addition to water, 0.5 to 20% by weight of hydrophobic silica, 0.01 to 10% by weight of a gelling additive, or viscosity-increasing additive which, as further components, contains at least one phenol or at least one phenol derivative and/or at least one aldehyde. It is prepared by dispersing the individual components successively or together in water, in which case the individual components are deaerated before and/or during the addition or the dispersion is deaerated during the individual dispersion steps and thereafter the residual air present in the dispersion is removed by application of vacuum. The dispersion can be used as insecticide and for controlling pathogenic agents. | 08-12-2010 |
Margit Lenninger, Egg AT
Patent application number | Description | Published |
---|---|---|
20150207149 | ELECTRODE FOR A GALVANIC CELL - An electrode for a galvanic cell, characterized by a carrier, which is provided with an embroidery, wherein at least a part of the surface of the embroidery is configured to be electrically conductive. | 07-23-2015 |
Margit Mahlapuu, Goteborg SE
Patent application number | Description | Published |
---|---|---|
20080267933 | Probiotics to Influence Fat Metabolism and Obesity - Use of probiotic bacteria for the manufacture of a food product, feed product, dietary supplement, nutritional product, natural remedy, pharmaceutical active formulation and medicinal product to be used for controlling weight gain, preventing obesity, increasing satiety, prolonging satiation, reducing food intake, reducing fat deposition, improving energy metabolism, enhancing insulin sensitivity, treating obesity and treating insulin insensitivity. The probiotic bacteria is at least one of | 10-30-2008 |
20110306565 | HYALURONIC ACID CONTAINING COMPOSITIONS FOR TREATMENT OF WOUNDS, SCARS, POST-SURGICAL ADHESION FORMATION - Pharmaceutical compositions are provided for enhancing the therapeutic effect of biologically active peptides, especially peptides derived from human lactoferrin. The compositions are useful for the treatment and/or prevention of wounds, scars, and post surgical adhesions. | 12-15-2011 |
20130310306 | HUMAN LACTOFERRIN DERIVED PEPTIDES AND THEIR USE - The present invention relates to new peptides and to use thereof, in particular for treatment and/or prevention of infections, inflammations, pain, wounds, scar and/or tumours. | 11-21-2013 |
20140031296 | NEW SYNTHETIC PEPTIDES AND THEIR USE - The present invention relates to new peptides and to use thereof, in particular for treatment and/or prevention of infections, inflammations, pain, wounds, scar and/or tumours. | 01-30-2014 |
20140349949 | HYALURONIC ACID CONTAINING COMPOSITIONS FOR TREATMENT OF WOUNDS, SCARS, POST-SURGICAL ADHESION FORMATION - The present invention relates to pharmaceutical compositions enhancing the therapeutic effect of biologically active peptides, especially peptides derived from human lactoferrin. The compositions are useful for the treatment and/or prevention of wounds, scars, and post surgical adhesions. | 11-27-2014 |
Margit Pedersen, Roskilde DK
Patent application number | Description | Published |
---|---|---|
20130203113 | METHOD OF STABILIZING mRNA - There is provided a method to increase the production of a desired protein in a microorganism by introduction of slowly translated codons in the encoding DNA gene sequence capable of slowing down the translation speed of the ribosomes moving along the mRNA, whereby the ribosomes protect the mRNA from being enzymatically degraded. This increases the stability of the mRNA transcript and thus results in an increased production of the desired protein. Moreover, there is provided a method of decreasing the half-life of a mRNA transcript from a gene encoding a peptide. | 08-08-2013 |
Margit Pfundstein, Weingarten DE
Patent application number | Description | Published |
---|---|---|
20110135849 | MULTILAYERED ELEMENTS, THE PRODUCTION THEREOF AND THE USE THEREOF - Multilayered articles comprise | 06-09-2011 |
Margit Rajamäki, Pori FI
Patent application number | Description | Published |
---|---|---|
20110278495 | PROCESS OF PREPARING ALKALI METAL TITANATES - A lithium titanate product, the formula of which is in the form of Li | 11-17-2011 |
Margit Roth, Freimersheim DE
Patent application number | Description | Published |
---|---|---|
20140165544 | MODULAR MANIFOLD FOR MOTOR VEHICLES - A modular exhaust manifold | 06-19-2014 |
20150152762 | EXHAUST-GAS HEAT EXCHANGER - An exhaust-gas heat exchanger for an exhaust system for cooling an exhaust-gas flow, having an inner pipe and an outer pipe, wherein the two pipes are indirectly or directly welded to one another in sealing fashion at the inlet side, a jacket pipe is arranged around the outside of the outer pipe and an annular gap for coolant is arranged between the outer pipe and the jacket pipe, and the inner pipe has an axial flow cross section (A | 06-04-2015 |
Margit Schluschke, Bruckmuehl DE
Patent application number | Description | Published |
---|---|---|
20150231563 | Method For Purifying Exhaust Gas And For Regenerating An Oxidation Catalyst - The invention relates to a method for purifying exhaust gas and for regenerating an oxidation catalytic converter, comprising treating the exhaust gas in an oxidation catalytic converter, which comprises a catalytically active material, which contains at least one noble metal and/or at least one base transition metal, wherein the oxidation catalytic converter is operated continuously or at times at a temperature that causes the oxidation of soot particles and/or carbon particles, and/or wherein the oxidation catalytic converter is periodically heated to a temperature that causes the oxidation of soot particles and/or carbon particles. | 08-20-2015 |
Margit Schuschke, Bruckmuehl DE
Patent application number | Description | Published |
---|---|---|
20140186251 | LOW-TEMPERATURE OXIDATION CATALYST WITH PARTICULARLY MARKED HYDROPHOBIC PROPERTIES FOR THE OXIDATION OF ORGANIC PULLUTANTS - The present invention relates to a catalyst comprising a macroporous noble metal-containing zeolite material and a porous SiO | 07-03-2014 |
Margit Steiner-Langlechner, Altoetting DE
Patent application number | Description | Published |
---|---|---|
20120123143 | METHOD FOR PRODUCING ALKOXY-SUBSTITUTED 1,2-BISSILYLETHANES - The invention relates to a method for producing alkoxy-substituted 1,2-bissilylethanes of the general formula 1 | 05-17-2012 |
Margit Teltschik, Karlstadt DE
Patent application number | Description | Published |
---|---|---|
20080248428 | Method for Producing Flexographic Printing Forms by Thermal Development - The invention relates to a method for producing flexographic printing forms by thermal development during which a flexographic printing element exposed in an image-like manner is developed by heating and removing the softened, non-polymerized portions of the relief-forming layer, whereby the flexographic printing element used contains a styrene butadiene block copolymer mixed with a softener, and the proportion of butadiene which is 1,2-coupled, ranges from 15 to 50% by weight of the block copolymer. | 10-09-2008 |
Margit Vallikivi, Princeton, NJ US
Patent application number | Description | Published |
---|---|---|
20150075280 | Fast Response Humidity Sensor - A water content sensor is disclosed. The sensor includes a wire filament configured with a Péclet number of 1 or less. The wire filament has an electrically conductive material with an electrical resistance that varies as a function of temperature. The sensor includes a pair of electrically conductive prongs coupled to opposite ends of the wire filament. Electrically conductive stubs may be coupled to the prongs. A structural support may be coupled to the prongs. The structural support structure may be comprised of silicon. The wire filament may be coupled to driving circuitry configured to supply an electric current to the wire filament to maintain the wire filament at one of an approximately constant current, an approximately constant voltage and an approximately constant temperature. The wire filament may be platinum or titanium. | 03-19-2015 |
Margit Veeh, Ulm DE
Patent application number | Description | Published |
---|---|---|
20150029743 | COMPONENT FOR THE EXTERIOR SURFACE OF A VEHICLE - A component ( | 01-29-2015 |
Margit Villing, Nieul Le Dolent FR
Patent application number | Description | Published |
---|---|---|
20100303210 | PHANTOM OBJECT FOR THE QUALITY CONTROL OF A DEVICE FOR RADIATION THERAPY TREATMENT AND METHODS FOR ITS MANUFACTURE AND ITS USE - This phantom object is designed for a Winston-Lutz test on a device for radiation therapy treatment comprising a patient support having a rotation axis (V), a stand having a rotation axis (H) and a collimator having a rotation axis (C), locating means being provided for visually representing the theoretical positions (V′, H′, C′) of the three axes (V, H, C). A spherical ball is positioned at the center of a sphere in a material of electron density lower than that of the ball, the ball and the sphere both constituting the phantom object. The sphere has on its outer surface means for a visual alignment with the locating means allowing a positioning of the phantom object at the point of convergence of the three axes (V′, H′, C′). | 12-02-2010 |
Margit Weghofer, Vienna AT
Patent application number | Description | Published |
---|---|---|
20090104208 | House Dust Mite Allergen - A polypeptide comprising an amino acid sequence having at least 60% identity to the amino acid sequence SEQ ID No. 1 or comprising at least one amino acid fragment of at least 6 consecutive amino acid residues of the amino acid sequence SEQ ID No. 1 or having immunological cross-reactivity to the amino acid sequence SEQ ID No. 1 or fragments thereof, wherein the amino acid sequence SEQ ID No. 1 codes for an allergen and the polypeptide comprises at least one T cell epitope recognized by a T cell receptor specific for a molecule having the amino acid sequence SEQ ID No. 1. | 04-23-2009 |
20150104458 | HOUSE DUST MITE ALLERGEN - A polypeptide containing an amino acid sequence having at least 60% identity to the amino acid sequence SEQ ID No. 1 or containing at least one amino acid fragment of at least 6 consecutive amino acid residues of the amino acid sequence SEQ ID No. 1 or having immunological cross-reactivity to the amino acid sequence SEQ ID No. 1 or fragments thereof, wherein the amino acid sequence SEQ ID No. 1 codes for an allergen and the polypeptide comprises at least one T cell epitope recognized by a T cell receptor specific for a molecule having the amino acid sequence SEQ ID No. 1. | 04-16-2015 |
Margit Weghofer, Wien AT
Patent application number | Description | Published |
---|---|---|
20150238585 | ANTI-HER2 VACCINE BASED UPON AAV DERIVED MULTIMERIC STRUCTURES - The present invention relates to parvovirus mutated structural proteins comprising insertions of mimotopes of a HER2, compositions, multimeric structures, medicaments and vaccines comprising the same, nucleic acids, expression cassettes, constructs, vectors and cells comprising the nucleic acids, methods of preparing the structural proteins and methods of inducing a B-cell response or of treating a HER2-related disease. | 08-27-2015 |
Margit Wissenbach, Fredensborg DK
Patent application number | Description | Published |
---|---|---|
20090318362 | OLIGOMERIC COMPOUNDS FOR THE MODULATION OF SURVIVIN EXPRESSION - Oligonucleotides directed against the survivin gene are provided for modulating the expression of survivin. The compositions comprise oligonucleotides, particularly antisense oligonucleotides, targeted to nucleic acids encoding the survivin. Methods of using these compounds for modulation of survivin expression and for the treatment of diseases associated with either overexpression of survivin, expression of mutated survivin or both are provided. Examples of diseases are cancer such as lung, breast, colon, prostate, pancreas, lung, liver, thyroid, kidney, brain, testes, stomach, intestine, bowel, spinal cord, sinuses, bladder, urinary tract or ovaries cancers. The oligonucleotides may be composed of deoxyribonucleosides or a nucleic acid analogue such as for example locked nucleic acid or a combination thereof. | 12-24-2009 |
20100292311 | OLIGOMERIC COMPOUNDS FOR THE MODULATION OF SURVIVIN EXPRESSION - Oligonucleotides directed against the survivin gene are provided for modulating the expression of survivin. The compositions comprise oligonucleotides, particularly antisense oligonucleotides, targeted to nucleic acids encoding the survivin. Methods of using these compounds for modulation of survivin expression and for the treatment of diseases associated with either overexpression of survivin, expression of mutated survivin or both are provided. Examples of diseases are cancer such as lung, breast, colon, prostate, pancreas, lung, liver, thyroid, kidney, brain, testes, stomach, intestine, bowel, spinal cord, sinuses, bladder, urinary tract or ovaries cancers. The oligonucleotides may be composed of deoxyribonucleosides or a nucleic acid analogue such as for example locked nucleic acid or a combination thereof. | 11-18-2010 |
20120088907 | OLIGOMERIC COMPOUNDS FOR THE MODULATION OF SURVIVIN EXPRESSION - Oligonucleotides directed against the survivin gene are provided for modulating the expression of survivin. The compositions comprise oligonucleotides, particularly antisense oligonucleotides, targeted to nucleic acids encoding the survivin. Methods of using these compounds for modulation of survivin expression and for the treatment of diseases associated with either overexpression of survivin, expression of mutated survivin or both are provided. Examples of diseases are cancer such as lung, breast, colon, prostate, pancreas, lung, liver, thyroid, kidney, brain, testes, stomach, intestine, bowel, spinal cord, sinuses, bladder, urinary tract or ovaries cancers. The oligonucleotides may be composed of deoxyribonucleosides or a nucleic acid analogue such as for example locked nucleic acid or a combination thereof. | 04-12-2012 |
20120322848 | LNA OLIGONUCLEOTIDES AND THE TREATMENT OF CANCER - The present disclosure concerns LNA oligonucleotides having a (sub)sequence of the general formula 5′-( | 12-20-2012 |